Compare stocks
Evaluate stocks side by side, to find the best fit for your investment goals.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
View stockAmazon is the leading online retailer and marketplace for third party sellers. Retail related revenue represents approximately 74% of total, followed by Amazon Web Services (17%), and advertising services (9%). International segments constitute 22% of Amazon's total revenue, led by Germany, the United Kingdom, and Japan.
View stockStock highlights
Stock name | Kenvue | Amazon |
|---|---|---|
Last price | $19.44 | $252.11 |
Currency | USD | USD |
| $37B | $2.8T | |
| 22.40 | 21.10 | |
| $0.85 | $12.44 | |
| 0.43 | 1.45 | |
| $1.04 | 0 | |
| 4.41% | 0 | |
Sector | Consumer Essentials | Consumer Essentials |
Employees | 21,890 | 1,576,000 |
Ticker | $KVUE | $AMZN |
Primary listing | NYSE | NASDAQ |
Performance
CumulativeRolling yearsLump sum investment
Invest in $KVUE or $AMZN on Lightyear
Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.